This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Registration Savings Deadline Expires In

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

Ying Cai
Executive Director, Manufacturing Sciences and Technology at Ultragenyx Pharmaceutical


Ying Cai is the Head of Manufacturing Sciences and Technology, and previously the head of downstream process development and formulation development at Ultragenyx Pharmaceutical. Ying has over 20 years’ experience in the pharmaceutical development and manufacturing of biologics from Sanofi, Biogen, Merck and several contract organizations.  Ying holds a Ph.D. in Chemical Engineering from the University of Arkansas.

Agenda Sessions

  • Viral Safety Evaluation for AAV Gene Therapy Manufacturing Platforms


Speakers at this event